Open AccessCOVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report
Author(s) -
Anna Sessa,
Alessandra Mazzola,
Chetana Lim,
M. Atif,
Juliana Pappatella,
Valérie Pourcher,
Olivier Scatton,
Filoména Conti
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i44.7076
Subject(s) - medicine , immunosuppression , tacrolimus , pneumonia , liver transplantation , anosmia , atypical pneumonia , surgery , vomiting , transplantation , covid-19 , infectious disease (medical specialty) , disease
Coronavirus disease (COVID) is a new and highly contagious infectious disease caused by the coronavirus (COVID-19 or severe acute respiratory syndrome coronavirus 2). There is limited data regarding the incidence and management of COVID-19 in immunocompromised patients' post-transplantation. In the pre-COVID-19 era, these patients were already at an increased risk of developing opportunistic infections. These often manifested with atypical symptoms.